Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-018-0977-y.

Title:
STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway | Journal of Experimental & Clinical Cancer Research
Description:
Background Cancer stem cells (CSCs) possess abilities of self-renewal and differentiation, have oncogenic potential and are regarded to be the source of cancer recurrence. However, the mechanism by which CSCs maintain their stemness remains largely unclear. Methods In this study, the cell line-derived ovarian CSCs (OCSCs), 3AO and Caov3, were enriched in serum-free medium (SFM). Differentially expressed proteins were compared between the OCSC subpopulation and parental cells using liquid chromatography (LC)-mass spectrometry (MS)/MS label-free quantitative proteomics. Sphere-forming ability assays, flow cytometry, quantitative real-time polymerase chain reaction (qPCR), western blotting, and in vivo xenograft experiments were performed to evaluate stemness. RNA-sequencing (RNA-seq) and pyrosequencing were used to reveal the mechanism by which STON2 negatively modulates the stem-like properties of ovarian cancer cells. Results Among the 74 most differentially expressed proteins, stonin 2 (STON2) was confirmed to be down-regulated in the OCSC subpopulation. We show that STON2 negatively modulates the stem-like properties of ovarian cancer cells, which are characterized by sphere formation, a CD44+CD24− ratio, and by CSC- and epithelial mesenchymal transition (EMT)-related markers. STON2 knockdown also accelerated tumorigenesis in NOD/SCID mice. Further investigation revealed a downstream target, mucin 1 (MUC1), as up-regulated upon the down regulation of STON2. A decrease in both DNA methyltransferase 1 (DNMT1) expression and methylation in the promoter region of MUC1 was associated with subsequently elevated MUC1 expression, as detected in STON2 knockdown in 3AO and Caov3 cells. Direct DNMT1 knockdown simultaneously elevated MUC1 expression. The functional significance of this STON2-DNMT1/MUC1 pathway is supported by the observation that STON2 overexpression suppresses MUC1-induced sphere formation of OCSCs. The paired expression of STON2 and MUC1 in ovarian cancer specimens was also detected revealing the prognostic value of STON2 expression to be highly dependent on MUC1 expression. Conclusions Our results imply that STON2 may negatively regulate stemness in ovarian cancer cells via DNMT1-MUC1 mediated epigenetic modification. STON2 is therefore involved in OCSC biology and may represent a therapeutic target for innovative treatments aimed at ovarian cancer eradication.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cells, cancer, muc, ston, expression, ovarian, pubmed, article, google, scholar, fig, analysis, stem, caov, cas, cell, usa, dna, methylation, data, dnmt, patients, additional, file, experiments, knockdown, stemlike, levels, spheroids, transfected, central, detected, overexpression, nanog, protein, level, cmyc, cultured, properties, survival, control, cdcd, shown, parental, culture, days, study, ocscs, low, figure,

Topics {✒️}

pi3k/akt/c-myc axis promotes wnt/beta-catenin signaling pathway 5-aza-2′-deoxycytidine-induced genome rearrangements significantly reduced cd44+cd24−phenotypes stem cell related-markers ha-tagged human muc1 dnmt1/muc1-mediated epigenetic mechanisms dnmt1-mediated epigenetic modification muc1-positive cell line platinum-resistant ovarian cancer lc-ms/ms analysis lc-ms/ms data usp7-mediated dnmt1 stabilization 10 μl/ml b27 additive cd44+cd24− cell population article download pdf cancer stem cell paired-end clean reads cpg dinucleotide-rich regions sphere-forming ability assay epithelial mesenchymal transition epithelial–mesenchymal transition epithelial-mesenchymal transition sphere-forming ability assays csc subpopulation-induced tumorigenicity ovarian cancer stem csc-related markers nanog ston2 overexpression-induced reduction ocsc-specific gene expressions aza dosage-dependent increase cancer stem cells ston2 knockdown-induced muc1 emt-related key factors ston2 knockdown-induced reduction ston2 modulates stem csc-related proteins showed ocsc-enriched population displays epithelial ovarian cancer paraffin-embedded tissue samples ston2-dnmt1/muc1 pathway 5 μg/ml puromycin serum muc1-specific antibodies emt-related protein expression ms/ms spectra pluripotent stem cells ferritin heavy chain privacy choices/manage cookies ston2 negatively modulates caov3 cell line 3ao cell line

Questions {❓}

  • Ovarian cancer stem cells: still an elusive entity?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway
         description:Cancer stem cells (CSCs) possess abilities of self-renewal and differentiation, have oncogenic potential and are regarded to be the source of cancer recurrence. However, the mechanism by which CSCs maintain their stemness remains largely unclear. In this study, the cell line-derived ovarian CSCs (OCSCs), 3AO and Caov3, were enriched in serum-free medium (SFM). Differentially expressed proteins were compared between the OCSC subpopulation and parental cells using liquid chromatography (LC)-mass spectrometry (MS)/MS label-free quantitative proteomics. Sphere-forming ability assays, flow cytometry, quantitative real-time polymerase chain reaction (qPCR), western blotting, and in vivo xenograft experiments were performed to evaluate stemness. RNA-sequencing (RNA-seq) and pyrosequencing were used to reveal the mechanism by which STON2 negatively modulates the stem-like properties of ovarian cancer cells. Among the 74 most differentially expressed proteins, stonin 2 (STON2) was confirmed to be down-regulated in the OCSC subpopulation. We show that STON2 negatively modulates the stem-like properties of ovarian cancer cells, which are characterized by sphere formation, a CD44+CD24− ratio, and by CSC- and epithelial mesenchymal transition (EMT)-related markers. STON2 knockdown also accelerated tumorigenesis in NOD/SCID mice. Further investigation revealed a downstream target, mucin 1 (MUC1), as up-regulated upon the down regulation of STON2. A decrease in both DNA methyltransferase 1 (DNMT1) expression and methylation in the promoter region of MUC1 was associated with subsequently elevated MUC1 expression, as detected in STON2 knockdown in 3AO and Caov3 cells. Direct DNMT1 knockdown simultaneously elevated MUC1 expression. The functional significance of this STON2-DNMT1/MUC1 pathway is supported by the observation that STON2 overexpression suppresses MUC1-induced sphere formation of OCSCs. The paired expression of STON2 and MUC1 in ovarian cancer specimens was also detected revealing the prognostic value of STON2 expression to be highly dependent on MUC1 expression. Our results imply that STON2 may negatively regulate stemness in ovarian cancer cells via DNMT1-MUC1 mediated epigenetic modification. STON2 is therefore involved in OCSC biology and may represent a therapeutic target for innovative treatments aimed at ovarian cancer eradication.
         datePublished:2018-12-05T00:00:00Z
         dateModified:2018-12-05T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-018-0977-y
         keywords:
            Ovarian cancer
            Cancer stem cell
            STON2
            MUC1
            DNMT1
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig7_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:37
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shanshan Xu
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yongfang Yue
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Songfa Zhang
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Caiyun Zhou
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Pathology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaodong Cheng
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xing Xie
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinyu Wang
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Weiguo Lu
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway
      description:Cancer stem cells (CSCs) possess abilities of self-renewal and differentiation, have oncogenic potential and are regarded to be the source of cancer recurrence. However, the mechanism by which CSCs maintain their stemness remains largely unclear. In this study, the cell line-derived ovarian CSCs (OCSCs), 3AO and Caov3, were enriched in serum-free medium (SFM). Differentially expressed proteins were compared between the OCSC subpopulation and parental cells using liquid chromatography (LC)-mass spectrometry (MS)/MS label-free quantitative proteomics. Sphere-forming ability assays, flow cytometry, quantitative real-time polymerase chain reaction (qPCR), western blotting, and in vivo xenograft experiments were performed to evaluate stemness. RNA-sequencing (RNA-seq) and pyrosequencing were used to reveal the mechanism by which STON2 negatively modulates the stem-like properties of ovarian cancer cells. Among the 74 most differentially expressed proteins, stonin 2 (STON2) was confirmed to be down-regulated in the OCSC subpopulation. We show that STON2 negatively modulates the stem-like properties of ovarian cancer cells, which are characterized by sphere formation, a CD44+CD24− ratio, and by CSC- and epithelial mesenchymal transition (EMT)-related markers. STON2 knockdown also accelerated tumorigenesis in NOD/SCID mice. Further investigation revealed a downstream target, mucin 1 (MUC1), as up-regulated upon the down regulation of STON2. A decrease in both DNA methyltransferase 1 (DNMT1) expression and methylation in the promoter region of MUC1 was associated with subsequently elevated MUC1 expression, as detected in STON2 knockdown in 3AO and Caov3 cells. Direct DNMT1 knockdown simultaneously elevated MUC1 expression. The functional significance of this STON2-DNMT1/MUC1 pathway is supported by the observation that STON2 overexpression suppresses MUC1-induced sphere formation of OCSCs. The paired expression of STON2 and MUC1 in ovarian cancer specimens was also detected revealing the prognostic value of STON2 expression to be highly dependent on MUC1 expression. Our results imply that STON2 may negatively regulate stemness in ovarian cancer cells via DNMT1-MUC1 mediated epigenetic modification. STON2 is therefore involved in OCSC biology and may represent a therapeutic target for innovative treatments aimed at ovarian cancer eradication.
      datePublished:2018-12-05T00:00:00Z
      dateModified:2018-12-05T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-018-0977-y
      keywords:
         Ovarian cancer
         Cancer stem cell
         STON2
         MUC1
         DNMT1
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0977-y/MediaObjects/13046_2018_977_Fig7_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:37
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shanshan Xu
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yongfang Yue
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Songfa Zhang
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Caiyun Zhou
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Pathology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaodong Cheng
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xing Xie
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinyu Wang
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Weiguo Lu
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:37
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Zhejiang University
      address:
         name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Pathology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shanshan Xu
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Yongfang Yue
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Songfa Zhang
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Caiyun Zhou
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Pathology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xiaodong Cheng
      affiliation:
            name:Zhejiang University
            address:
               name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xing Xie
      affiliation:
            name:Zhejiang University
            address:
               name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xinyu Wang
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Weiguo Lu
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Department of Pathology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
      name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
      name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China
      name:Department of Gynecologic Oncology; Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Women’s Reproductive Health Laboratory of Zhejiang Province; Women’s Hospital; School of Medicine, Zhejiang University, Hangzhou, China

External Links {🔗}(215)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.49s.